lymphoma

Showing NaN - NaN of 119

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Leukemia, Hematopoietic and Lymphoid System Tumor, Lymphoma Trial in Scottsdale, Rochester (procedure, behavioral,

Recruiting
  • Chronic Leukemia
  • +4 more
  • Acupuncture Therapy
  • +15 more
  • Scottsdale, Arizona
  • +1 more
Sep 29, 2023

Lymphoma Trial in Rochester (Carvedilol, Lisinopril, Pravastatin)

Recruiting
  • Lymphoma
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Lymphoma Trial in Rochester (drug, other, behavioral)

Recruiting
  • Lymphoma
  • Magnesium Chloride-based Lotion
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)

Completed
  • Lymphoma
  • HIV
  • Autologous transplant
  • +4 more
  • Duarte, California
  • +15 more
Dec 6, 2022

Solid Tumors, Lymphoma Trial in Worldwide (ASTX660)

Active, not recruiting
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +68 more
Nov 18, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Lymphoma Trial in United States (biological, drug, radiation)

    Active, not recruiting
    • Lymphoma
    • rituximab
    • +5 more
    • Anchorage, Alaska
    • +258 more
    Sep 23, 2022

    Solid Tumor, Lymphoma Trial in China, United States (TJ011133, Pembrolizumab, Rituximab)

    Active, not recruiting
    • Solid Tumor
    • Lymphoma
    • Birmingham, Alabama
    • +20 more
    Aug 22, 2022

    Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +49 more
    • Birmingham, Alabama
    • +1429 more
    Aug 17, 2022

    Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)

    Completed
    • Lymphoma
    • Nonneoplastic Condition
    • bleomycin sulfate
    • +11 more
    • Tucson, Arizona
    • +422 more
    Aug 16, 2022

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +7 more
    • Duarte, California
    • +26 more
    Aug 11, 2022

    Lymphoma Trial in Worldwide (CC-220, Rituximab, Obinutuzumab)

    Recruiting
    • Lymphoma
    • Phoenix, Arizona
    • +36 more
    Jul 28, 2022

    Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

    Active, not recruiting
    • Hematopoietic and Lymphoid System Neoplasm
    • +3 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +3 more
    • Birmingham, Alabama
    • +42 more
    Jul 20, 2022

    Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder Trial in Rochester (radiation, drug, procedure)

    Recruiting
    • Acute Leukemia
    • +9 more
    • Total Body Irradiation 1200 cGy
    • +7 more
    • Rochester, New York
      Wilmot Cancer Institute
    Jun 20, 2022

    Lymphoma Trial in United States (rituximab, Bendamustin, bortezomib)

    Active, not recruiting
    • Lymphoma
    • rituximab
    • +3 more
    • Greenbrae, California
    • +226 more
    Mar 7, 2022

    Lymphoma, Acute Lymphoblastic Leukemia Trial in Worldwide (Apixaban, No systemic anticoagulant prophylaxis)

    Completed
    • Lymphoma
    • Acute Lymphoblastic Leukemia
    • Apixaban
    • No systemic anticoagulant prophylaxis
    • Phoenix, Arizona
    • +95 more
    Feb 10, 2022

    Integrating 4 Measures to Assess Physical Function in Cancer

    Recruiting
    • Physical Function
    • +5 more
    • PRO Instruments assessment questionnaire
    • +4 more
    • New Haven, Connecticut
    • +1 more
    Feb 7, 2022

    Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (Durvalumab, Lenalidomide, Rituximab)

    Active, not recruiting
    • Lymphoma
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Gilbert, Arizona
    • +53 more
    Jan 25, 2022

    Lymphoma Trial in Scottsdale, Jacksonville, Rochester (biological, drug, genetic, other)

    Active, not recruiting
    • Lymphoma
    • pegfilgrastim
    • +8 more
    • Scottsdale, Arizona
    • +2 more
    Jan 7, 2022

    Lymphoma Trial in United States (biological, drug, radiation)

    Completed
    • Lymphoma
    • rituximab
    • +7 more
    • Anchorage, Alaska
    • +47 more
    Dec 22, 2021

    Lymphoma Trial in Worldwide (Nivolumab)

    Completed
    • Lymphoma
    • Phoenix, Arizona
    • +44 more
    Dec 13, 2021

    Breast Cancer, Lymphoma Trial in United States (Atorvastatin, Placebo)

    Completed
    • Breast Cancer
    • Lymphoma
    • Los Angeles, California
    • +50 more
    Dec 6, 2021

    Lymphoma Trial in Worldwide (Nivolumab)

    Completed
    • Lymphoma
    • Birmingham, Alabama
    • +49 more
    Nov 24, 2021

    Hematological Disease, Immune Deficiencies, Solid Tumors Trial in Rochester (radiation, drug, procedure)

    Completed
    • Hematological Disease
    • +5 more
    • Total Body Irradiation 1200 cGy
    • +9 more
    • Rochester, New York
      Wilmot Cancer Institute
    Nov 1, 2021

    Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia Trial in United States (Mobilized Peripheral Blood Stem Cell

    Active, not recruiting
    • Acute Leukemia
    • +3 more
    • Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate
    • +5 more
    • Birmingham, Alabama
    • +38 more
    Oct 25, 2021